M/21/079 – Uniphar/NaviCorp
The proposed acquisition by Uniphar plc of sole control of NaviCorp Limited (trading as Navi Group) has been notified to the Competition and Consumer Protection Commission.
|Notification date||Decision date|
|Friday December 24, 2021|
|Parties Involved||Business activities|
Headquartered in Dublin, Uniphar plc is an Irish-incorporated public limited company traded on Euronext Dublin and the London Stock Exchange. It is an international diversified healthcare services business, servicing the requirements of more than 200 multinational pharmaceutical and medical technology manufacturers across three sectors/divisions - commercial & clinical, product access and supply chain & retail.
NaviCorp Limited is a pharmacy solutions business. Headquartered in Dublin, NaviCorp specialises in product buying and trading, the development of market leading IT systems for use in pharmacies and retail pharmacy franchise services. NaviCorp's group operates under four main divisions, namely (i) brokerage, (ii) technology, (iii) retail and (iv) trading.
|Economic sector||Media merger|
|Other Retail (Pharmacy)||No|
|Submissions from third parties due by:|
|Phase 1||Phase 2|
|Thursday, January 6, 2022||Monday, May 16, 2022|
|Date of Requirement for Information||Date Information Received|
|Monday, February 7, 2022||Thursday, March 10, 2022|
|Current status: Active|
|Full investigation (Phase 2)|
|Authorised Officer Assigned||Contact Details|
Media enquiries: firstname.lastname@example.org